APP and angioedema: Reduced activity of aminopeptidase P (APP) and dipeptidyl peptidase-IV (DPP-IV) has been associated with a heightened risk of ACEI-induced angioedema [9,11], and genetic variants of the XPNPEP2 gene (encoding APP) have been linked to increased vulnerability in genome-wide studies [12].